Press Releases

LAVAL, QC / ACCESSWIRE / May 14, 2024 / Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) and its gastroenterology business Salix Pharmaceuticals, today announced certain updates related to its litigation with Norwich Pharmaceuticals, Inc.

With respect to the April 11, 2024, decision of the US Court of Appeals for the Federal Circuit, both Bausch Health and Norwich have filed petitions for panel rehearing or rehearing en banc. The Company anticipates a decision on... (continue reading...)

• Published Phase 1 data of SON-1010 in Frontiers in Immunology demonstrating the safety and tolerability of the F H AB-derived Interleukin 12 in healthy volunteers
• Announced early safety data from the company's Phase 1b/2a clinical trial of SON-080 in patients with chemotherapy-induced peripheral neuropathy (CIPN)
• Received $4.3 million in net proceeds from the sale of net operating losses through the New Jersey Technology Business Tax Certificate Transfer Program
• Presented... (continue reading...)

Rejuvine Life, dedicated to developing natural healthcare solutions, today announced a crowdfunding campaign to expand its U.S. product line and advance diabetes research management. According to the announcement, the company utilizes natural resources to support the millions worldwide living with diabetes. Skordo Plus, Rejuvine Life’s leading product, is a garlic-based supplement designed to help regulate blood sugar levels and enhance overall well-being. “We... (continue reading...)

BEIJING, May 14, 2024 (GLOBE NEWSWIRE) -- Luokung Technology Corp. (NASDAQ: LKCO) (“Luokung” or the “Company”), a leading spatial-temporal intelligent big data services company and provider of interactive location-based services (“LBS”) and high-definition maps (“HD Maps”) in China, today announced that on May 2, 2024, the Company received a notice from the NASDAQ Stock Market (the “Nasdaq Notice”), notifying the Company that it is not in... (continue reading...)

ST. PAUL, Minn., May 14, 2024 /PRNewswire/ -- The 3M Board of Directors (NYSE: MMM) today declared a dividend on the company's common stock of $0.70 per share for the second quarter of 2024. The dividend is payable June 12, 2024, to shareholders of record at the close of business on May 24, 2024.

3M has paid dividends to its shareholders without interruption for more than 100 years.

As of March 31, 2024, 3M had 553,361,257 common shares outstanding and 59,380... (continue reading...)